Sprayable Dual‐Network Microgel Adhesive for Robust Wet Adhesion and Prolonged Analgesia in Complex Wounds
Source abstract
Abstract
ABSTRACT Managing deep, irregular wounds remains challenging due to poor suturability, persistent bleeding‐induced wet environments, and neuropathic pain. Here, we have developed a sprayable dual‐network microgel adhesive (PR) that rapidly covers complex wound geometries, combining strong wet tissue adhesion with sustained ropivacaine release. The sprayable powder format allows PR microgels to penetrate and adhere to irregular wound beds that conventional dressings cannot reach, with uniform particle size ensuring complete wound protection. Notably, PR maintains exceptional wet adhesion (∼40 kPa, over four times stronger than fibrin glue), enabling reliable sealing even under active bleeding conditions where liquid adhesives fail. The spray application simultaneously delivers liposomal ropivacaine, providing sustained analgesia (240 h release) that maintains pain‐free mobility for over 168 h post‐operation in rodent models. This on‐demand sprayable platform addresses key limitations in wound management by integrating instant hemostatic adhesion with prolonged pain relief in a single conformable format, demonstrating significant potential for clinical application.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Surgical Sutures and Adhesives · Polymer Surface Interaction Studies · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Anesthesiology Hangzhou Institute of Medicine (HIM) Zhejiang Cancer Hospital Chinese Academy of Sciences Hangzhou Zhejiang China
Graduate School of Wannan Medical College Wuhu Anhui China
Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
Funding
Natural Science Foundation of Shanghai Municipality
References (58)
Show source-provided references
1. 10.1056/NEJM19990902341100610.1056/NEJM199909023411006 ↗
2. 10.1016/j.pmatsci.2024.10124910.1016/j.pmatsci.2024.101249 ↗
3. 10.1038/nature0703910.1038/nature07039 ↗
4. 10.1038/jid.2011.21210.1038/jid.2011.212 ↗
5. 10.1016/j.cej.2021.13091610.1016/j.cej.2021.130916 ↗
6. 10.1039/c2bm00121g10.1039/c2bm00121g ↗
7. 10.1001/jamasurg.2018.103910.1001/jamasurg.2018.1039 ↗
8. 10.1016/j.biomaterials.2024.12293610.1016/j.biomaterials.2024.122936 ↗
9. 10.1136/bmjopen‐2015‐00925710.1136/bmjopen‐2015‐009257 ↗
10. 10.1021/acs.biomac.0c0106910.1021/acs.biomac.0c01069 ↗
11. 10.1016/j.cej.2021.13337210.1016/j.cej.2021.133372 ↗
12. 10.1126/science.aah636210.1126/science.aah6362 ↗
13. 10.1016/j.cej.2025.16416310.1016/j.cej.2025.164163 ↗
14. 10.1016/j.smaim.2021.11.00410.1016/j.smaim.2021.11.004 ↗
15. 10.1016/j.colcom.2024.10080910.1016/j.colcom.2024.100809 ↗
16. 10.1002/adma.20230870110.1002/adma.202308701 ↗
17. 10.1038/s41467‐025‐58204‐810.1038/s41467‐025‐58204‐8 ↗
18. 10.7150/thno.7963910.7150/thno.79639 ↗
19. 10.1002/mabi.20250020510.1002/mabi.202500205 ↗
20. 10.1016/j.biomaterials.2025.12308210.1016/j.biomaterials.2025.123082 ↗
21. 10.1002/adhm.20210001210.1002/adhm.202100012 ↗
22. 10.3390/gels1102013110.3390/gels11020131 ↗
23. 10.4103/0019‐5049.7987510.4103/0019‐5049.79875 ↗
24. 10.7759/cureus.7004010.7759/cureus.70040 ↗
25. 10.1016/j.jclinane.2024.11169410.1016/j.jclinane.2024.111694 ↗
26. 10.1038/s41551‐021‐00769‐y10.1038/s41551‐021‐00769‐y ↗
27. 10.1126/scitranslmed.abh285710.1126/scitranslmed.abh2857 ↗
28. 10.1016/j.anclin.2017.01.01810.1016/j.anclin.2017.01.018 ↗
29. 10.1001/jamasurg.2024.204410.1001/jamasurg.2024.2044 ↗
30. 10.1038/s41586‐019‐1710‐510.1038/s41586‐019‐1710‐5 ↗
31. 10.1021/acsami.5c0771610.1021/acsami.5c07716 ↗
32. 10.1016/j.porgcoat.2023.10815410.1016/j.porgcoat.2023.108154 ↗
33. 10.1038/s41598‐024‐57851‐z10.1038/s41598‐024‐57851‐z ↗
34. 10.1002/adhm.20240242010.1002/adhm.202402420 ↗
35. 10.1126/sciadv.adg403110.1126/sciadv.adg4031 ↗
36. 10.1007/s00595‐014‐1056‐410.1007/s00595‐014‐1056‐4 ↗
37. 10.1016/j.jvsv.2023.03.01810.1016/j.jvsv.2023.03.018 ↗
38. 10.1002/advs.20230332610.1002/advs.202303326 ↗
39. 10.1111/jphp.1268010.1111/jphp.12680 ↗
40. 10.1002/ame2.1204110.1002/ame2.12041 ↗
41. 10.1016/j.ijpharm.2025.12583010.1016/j.ijpharm.2025.125830 ↗
42. 10.1016/j.ejphar.2019.01.00910.1016/j.ejphar.2019.01.009 ↗
43. 10.1016/j.actbio.2022.08.03610.1016/j.actbio.2022.08.036 ↗
44. 10.1111/jnc.1500610.1111/jnc.15006 ↗
45. 10.1016/j.actbio.2011.04.02210.1016/j.actbio.2011.04.022 ↗
46. 10.1590/s0365‐0596201200060000810.1590/s0365‐05962012000600008 ↗
47. 10.1002/jbm.b.3269410.1002/jbm.b.32694 ↗
48. 10.1016/j.joca.2015.03.00110.1016/j.joca.2015.03.001 ↗
49. 10.1007/s42765‐024‐00422‐810.1007/s42765‐024‐00422‐8 ↗
50. 10.1002/advs.20230948210.1002/advs.202309482 ↗
51. 10.1007/s42765‐024‐00486‐610.1007/s42765‐024‐00486‐6 ↗
52. 10.1016/j.biocel.2004.02.02310.1016/j.biocel.2004.02.023 ↗
53. 10.1002/glia.2434310.1002/glia.24343 ↗
54. 10.1016/j.tins.2020.01.00310.1016/j.tins.2020.01.003 ↗
55. 10.11477/mf.141620183810.11477/mf.1416201838 ↗
56. 10.1016/j.biopha.2023.11571410.1016/j.biopha.2023.115714 ↗
57. 10.1111/iwj.1494210.1111/iwj.14942 ↗
58. 10.1038/s41570‐021‐00323‐z10.1038/s41570‐021‐00323‐z ↗